Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microencapsulated cells as hormone delivery systems.

A M Sun1, M F Goosen, G O'Shea

  • 1Department of Physiology, University of Toronto, Ontario, Canada.

Critical Reviews in Therapeutic Drug Carrier Systems
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinoma.

Neoplasma·2020
Same author

Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection.

Neoplasma·2017
Same author

Immobilization of insect cells.

Cytotechnology·2012
Same author

Hrd1 facilitates tau degradation and promotes neuron survival.

Current molecular medicine·2012
Same author

Methods for the immunoisolation and transplantation of pancreatic cells.

Methods in molecular medicine·2011
Same author

Members of the Kv1 and Kv2 voltage-dependent K(+) channel families regulate insulin secretion.

Molecular endocrinology (Baltimore, Md.)·2001

Encapsulating pancreatic islets in alginate-polylysine membranes prevents immune rejection, offering a promising strategy for treating diabetes and other hormone deficiency diseases.

Area of Science:

  • Biomedical Engineering
  • Endocrinology
  • Immunology

Background:

  • Diabetes complications can be prevented by pancreatic islet transplantation.
  • Immune rejection is a major barrier to successful islet transplantation.
  • Artificial membranes can prolong islet allograft survival in animal models.

Purpose of the Study:

  • To develop and evaluate a microencapsulation technique for pancreatic islets.
  • To assess the efficacy of encapsulated islets in preventing immune rejection and reversing diabetes in a rodent model.

Main Methods:

  • Developing a microencapsulation method using alginate and polylysine semipermeable membranes.
  • Creating capsules of 700-800 micron diameter with a 4-micron thick hydrogel membrane.
  • Performing intraperitoneal allografts of 5 x 10^3 encapsulated islets in diabetic rats.

Related Experiment Videos

Main Results:

  • Encapsulated islet allografts reversed diabetes in rats for up to 21 months.
  • Intact microcapsules containing viable beta cells were recovered from recipients.
  • The microencapsulation technique is applicable to other endocrine cell types.

Conclusions:

  • Microencapsulation of endocrine cells is a viable strategy to overcome immune rejection in transplantation.
  • This approach holds potential for the clinical treatment of hormone deficiency diseases, including diabetes.
  • Further research may lead to improved diabetes management through cell encapsulation therapies.